BRCA1 and BRCA2 germ-line mutations and oral contraceptives: To use or not to use

Breast

Volumn 14, Issue 4, 2005, Pages 264-268

  Grenader, Tal ^a   Peretz, Tamar ^a   Lifchitz, Meyer ^b   Shavit, Linda ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

BRCA1 and BRCA2 germ line mutations; Breast cancer; Oral contraception; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GONADOTROPIN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BIRTH CONTROL; BREAST CANCER; CALCULATION; CANCER PREVENTION; CANCER RISK; DECISION MAKING; DRUG MECHANISM; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG WITHDRAWAL; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERM LINE; HORMONE INHIBITION; HUMAN; LIFESPAN; MASTECTOMY; ORAL CONTRACEPTION; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGICAL TECHNIQUE;

EID: 23444438332     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.01.005     Document Type: Article

References (29)

1. H.L. Howe P.A. Wingo M.J. Thun et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends J Natl Cancer Inst 93 11 2001 824-842
2. J. Menczer A. Chetrit G. Barda et al. Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women Gynecol Oncol 88 1 2003 58-61
3. L.C. Brody B.B. Biesecker Breast cancer susceptibility genes. BRCA1 and BRCA2 Medicine (Baltimore) 77 1998 208-226
4. D. Ford D.F. Easton J. Peto Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1995 1457-1462
5. B. Newman M.A. Austin M. Lee M.C. King Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families Proc Natl Acad Sci USA 85 1988 3044-3048
6. J.P. Struewing P. Hartge S. Wacholder et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1997 1401-1408
7. T.C. Rosenthal S.M. Puck Screening for genetic risk of breast cancer Am Fam Physician 59 1999 99-104
8. D. Ford D.F. Easton M. Stratton et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 3 1998 676-689
9. R. Chen-Shtoyerman A. Figer H.H. Fidder et al. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients Br J Cancer 84 4 2001 475-477
10. A. Vazina J. Baniel Y. Yaacobi et al. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel Br J Cancer 83 4 2000 463-466
11. S.A. Narod M.P. Dube J. Klijn et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 94 23 2002 1773-1779
12. O.T. Johannsson I. Idvall C. Anderson et al. Tumor biological features of BRCA1-induced breast and ovarian cancer Eur J Cancer 33 3 1997 362-371
13. S.E. Karp P.N. Tonin L.R. Begin et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women Cancer 80 3 1997 435-441
14. T.R. Rebbeck A.M. Levin A. Eisen et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91 17 1999 1475-1479
15. S.A. Narod J.S. Brunet P. Ghadirian et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study. Hereditary Breast Cancer Clinical Study Group Lancet 356 9245 2000 1876-1881
16. L. Kaduri M. Gibs A. et al. Hubert Genetic testing of breast and ovarian cancer patients: Clinical characteristics and hormonal risk modifiers Eur J Obstet Gynecol Reprod Biol 85 1 1999 75-80
17. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer Lancet 1996;347:1713-27.
18. A.S. Whittemore R. Harris J. Itnyre Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group Am J Epidemiol 136 10 1992 1212-1220
19. S. Franceschi F. Parazzini E. Negri et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use Int J Cancer 49 1 1991 61-65
20. G.C. Rodriguez D.K. Walmer M. Cline et al. Effect of progestin on the ovarian epithelium of macaques: Cancer prevention through apoptosis? J Soc Gynecol Investig 5 5 1998 271-276
21. S.A. Narod H. Risch R. Moslehi et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group N Engl J Med 339 7 1998 424-428
22. B. Modan P. Hartge G. Hirsh-Yechezkel et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation N Engl J Med 345 4 2001 235-240
23. S.A. Narod P. Sun H.A. Risch Ovarian cancer, oral contraceptives, and BRCA mutations N Engl J Med 345 23 2001 1706-1707
24. L.C. Hartmann D.J. Schaid J.E. Woods et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 340 1999 77-84
25. N.D. Kauff J.M. Satagopan M.E. Robson et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 2002 1609-1615
26. W. Burke M. Daly J. Garber et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium J Am Med Assoc 277 1997 997-1003
27. C.K. Kuhl R.K. Schmutzler C.C. Leutner et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results Radiology 215 2000 267-279
28. M.J. Stoutjesdijk C. Boetes G.J. Jager et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer J Natl Cancer Inst 93 2001 1095-1102
29. M.C. King J.H. Marks J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 2003 643-646